...
首页> 外文期刊>Journal of Computer-Aided Molecular Design >Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps
【24h】

Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps

机译:双(羟基苯基)芳烃在17β-HSD1中的结合模式的计算研究:分子动力学模拟,MM-PBSA自由能计算和分子静电势图

获取原文
获取原文并翻译 | 示例

摘要

17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the last step of the estrogen biosynthesis, namely the reduction of estrone to the biologically potent estradiol. As such it is a potentially attractive drug target for the treatment of estrogen-dependent diseases like breast cancer and endometriosis. 17β-HSD1 belongs to the bisubstrate enzymes and exists as an ensemble of conformations. These principally differ in the region of the βFαG′-loop, suggesting a prominent role in substrate and inhibitor binding. Although several classes of potent non-steroidal 17β-HSD1 inhibitors currently exist, their binding mode is still unclear. We aimed to elucidate the binding mode of bis(hydroxyphenyl)arenes, a highly potent class of 17β-HSD1 inhibitors, and to rank these compounds correctly with respect to their inhibitory potency, two essential aspects in drug design. Ensemble docking experiments resulted in a steroidal binding mode for the closed enzyme conformations and in an alternative mode for the opened and occluded conformers with the inhibitors placed below the NADPH interacting with it synergically via π–π stacking and H-bond formation. Both binding modes were investigated by MD simulations and MM-PBSA binding free energy estimations using as representative member for this class compound 1 (50 nM). Notably, only the alternative binding mode proved stable and was energetically more favorable, while when simulated in the steroidal binding mode compound 1 was displaced from the active site. In parallel, ab initio studies of small NADPH-inhibitor complexes were performed, which supported the importance of the synergistic interaction between inhibitors and cofactor.
机译:1型17β-羟基类固醇脱氢酶(17β-HSD1)催化雌激素生物合成的最后一步,即将雌酮还原为具有生物活性的雌二醇。因此,它是治疗诸如乳腺癌和子宫内膜异位的雌激素依赖性疾病的潜在有吸引力的药物靶标。 17β-HSD1属于双底物酶,以构象整体形式存在。这些主要在βFαG'-环的区域不同,表明在底物和抑制剂结合中起显著作用。尽管目前存在几种有效的非类固醇17β-HSD1抑制剂,但它们的结合方式仍不清楚。我们的目的是阐明双(羟苯基)芳烃的结合模式,这是一类非常有效的17β-HSD1抑制剂,并针对这些化合物在药物设计中的两个重要方面,对它们的抑制能力进行了正确分类。整体对接实验产生了封闭酶构象的甾体结合模式,以及打开和封闭的构象体的替代模式,NADPH下方的抑制剂通过π-π堆积和氢键形成与其相互作用。两种结合模式均通过MD模拟和MM-PBSA结合自由能估计(以此类化合物1(50 nM)为代表)进行了研究。值得注意的是,只有替代的结合模式被证明是稳定的,并且在能量上更有利,而当以类固醇结合模式进行模拟时,化合物1从活性位点被取代。同时,进行了小NADPH-抑制剂复合物的从头算研究,这支持了抑制剂与辅因子之间协同相互作用的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号